Presentations:
4DMT: Intravitreal Gene Therapy With 4D-150: Advancing Clinical Evidence of a Potential Backbone Therapy in nAMD and DME
Location: Schubert 1
Date & Time: Saturday, 3rd October, 10:15 – 11:15 CEST
Chairperson(s): G. Cheung (Singapore)
Speakers:
G. Cheung (Singapore)
10:15 Setting the Stage: Why Continuous Retinal Disease Requires Continuous Treatment
S. Sivaprasad (UK)
10:25 Inside the Design of Gene Therapy: How Fundamental Concepts Drive Mechanisms of Action and Purposeful Design
P. Schlottmann (Argentina)
10:35 Backbone Therapy for nAMD: Redefining Success and How 4D-150 is Positioned to Become Foundational for nAMD Care
D. Sambhara (USA)
10:43 PRISM and 4FRONT: Key Clinical Data and Phase 3 Study Design Rationale
D. Sambhara (USA)
10:55 SPECTRA: A Paradigm Shift for Treatment of DME
G. Cheung (Singapore)
10:55 Panel Discussion
G. Cheung (Singapore)
11:09 Audience Questions